Page last updated: 2024-11-07

penicillamine and Depression, Endogenous

penicillamine has been researched along with Depression, Endogenous in 3 studies

Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.

Research Excerpts

ExcerptRelevanceReference
" (1) The chronic administration of isoniazid for the prevention or treatment of tuberculosis can produce peripheral neuropathy which can be prevented by the concurrent administration of pyridoxine."2.36Drug-pyridoxal phosphate interactions. ( Al-Sayegh, A; Ebadi, M; Gessert, CF, 1982)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chan, KH1
Cheung, RT1
Au-Yeung, KM1
Mak, W1
Cheng, TS1
Ho, SL1
Srinivas, K1
Sinha, S1
Taly, AB1
Prashanth, LK1
Arunodaya, GR1
Janardhana Reddy, YC1
Khanna, S1
Ebadi, M1
Gessert, CF1
Al-Sayegh, A1

Reviews

1 review available for penicillamine and Depression, Endogenous

ArticleYear
Drug-pyridoxal phosphate interactions.
    Quarterly reviews on drug metabolism and drug interactions, 1982, Volume: 4, Issue:4

    Topics: Animals; Contraceptives, Oral, Hormonal; Depressive Disorder; Disease; Drug Interactions; Drug Thera

1982

Other Studies

2 other studies available for penicillamine and Depression, Endogenous

ArticleYear
Wilson's disease with depression and parkinsonism.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2005, Volume: 12, Issue:3

    Topics: Adult; Antiparkinson Agents; Brain; Bromocriptine; Chelating Agents; Depressive Disorder; Female; He

2005
Dominant psychiatric manifestations in Wilson's disease: a diagnostic and therapeutic challenge!
    Journal of the neurological sciences, 2008, Mar-15, Volume: 266, Issue:1-2

    Topics: Adolescent; Adult; Chelating Agents; Cohort Studies; Copper; Depressive Disorder; Female; Follow-Up

2008